Healthcare data for the financial world.
Utilize low-latency, transparent, big data solutions to merge finance, healthcare,
and AI.
Financial-first findings you can trust.
Access unparalleled healthcare datasets to develop your financial models and investment
strategies.
90B+
Total Claim Events
330M+
Unique Medical & Pharma Patients
500K+
Total Number of Unique Organizations
2.7M+
Total Number of Unique Providers
90K+
Total Number of Unique Diagnosis
1.5K+
Medical & Pharma Tickers Mapped
4K+
Pharma Manufacturers
11+
Years of Historical Data
Research
Use healthcare data to run effective finance models.
SEAMLESS
Integrates with your workflow
Our data experts work with you closely, delivering case study analytics that sync
effortlessly with your existing setup
Scalable
Capital efficient
Large datasets coupled with expert analysis at cost-effective prices
Speed
Daily, transparent delivery
Delays are costly. Realize unbiased insights months ahead of the competition
Limitless
Build models big and small
Don’t get stuck in noisy data. Clear inputs for solutions from bespoke to large
scale
CASE STUDIES
Real data. Real insights.
Quarterly claims data reveals the explosive growth of GLP-1 drugs — who's prescribing, who's paying, and where the market is heading.
Quarterly claims data reveals the explosive growth of ADC Oncology drugs — who's prescribing, who's paying, and where the market is heading.
From diabetes drug to cardiovascular cornerstone — IMX Data tracks 10 years of SGLT-2i claim volume, market share, payer friction, and indication shifts.
8 years of retinal-injection claims track the shift from off-label Avastin and Eylea toward durable next-gen agents — agent mix, real-world dosing intervals, site of care, and payer.
Pharmacy and medical claims linked on the same patient track the IL-23 class from the p40 originator to p19-selective agents and the first oral — benefit mix, real-world dosing intervals, indication mix, prescriber specialty, and post-LOE biosimilar erosion.
"For too long, healthcare data has been scattered and siloed. We’re here to clear the
data fog and give finance experts a clear path to unlocking its potential. This is the
vision guiding my team."
Jim Plante
CEO
CEO
Frequently Asked Questions
Everything you need to know about IMX Data
Healthcare claims data built for institutional investors, hedge funds, and quant funds. Can't find what you're looking for? Contact us.
SOC 2 Type II Certified
All data de-identified per HIPAA Safe Harbor (45 CFR 164.514(b)). SOC 2 Type II
certified in 2025. Enterprise-grade security and compliance for institutional clients.
Ready to dive in?
Begin designing your data solution today.